FA
FDx Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-292
| Closed | -$281K | – | 321 |
|
|
2024
Q1 | $281K | Sell |
292
-690
| -70% | -$664K | 0.04% | 303 |
|
|
2023
Q4 | $862K | Buy |
982
+240
| +32% | +$211K | 0.07% | 289 |
|
|
2023
Q3 | $611K | Sell |
742
-1,243
| -63% | -$1.02M | 0.05% | 310 |
|
|
2023
Q2 | $1.43M | Buy |
1,985
+586
| +42% | +$421K | 0.08% | 245 |
|
|
2023
Q1 | $1.01M | Hold |
1,399
| – | – | 0.04% | 293 |
|
|
2022
Q4 | $1.01M | Sell |
1,399
-757
| -35% | -$546K | 0.04% | 293 |
|
|
2022
Q3 | $1.49M | Sell |
2,156
-623
| -22% | -$429K | 0.07% | 223 |
|
|
2022
Q2 | $1.64M | Sell |
2,779
-740
| -21% | -$438K | 0.06% | 235 |
|
|
2022
Q1 | $2.46M | Sell |
3,519
-12
| -0.3% | -$8.38K | 0.08% | 188 |
|
|
2021
Q4 | $2.23M | Buy |
3,531
+1,807
| +105% | +$1.14M | 0.06% | 222 |
|
|
2021
Q3 | $1.04M | Sell |
1,724
-22
| -1% | -$13.3K | 0.03% | 327 |
|
|
2021
Q2 | $975K | Sell |
1,746
-447
| -20% | -$250K | 0.03% | 344 |
|
|
2021
Q1 | $1.04M | Sell |
2,193
-43,038
| -95% | -$20.4M | 0.04% | 285 |
|
|
2020
Q4 | $21.9M | Buy |
45,231
+986
| +2% | +$476K | 0.9% | 27 |
|
|
2020
Q3 | $24.8M | Buy |
44,245
+3,272
| +8% | +$1.83M | 1.16% | 24 |
|
|
2020
Q2 | $25.6M | Buy |
40,973
+435
| +1% | +$271K | 1.34% | 18 |
|
|
2020
Q1 | $19.8M | Buy |
40,538
+4,421
| +12% | +$2.16M | 1.29% | 18 |
|
|
2019
Q4 | $13.6M | Buy |
36,117
+17,295
| +92% | +$6.49M | 0.75% | 31 |
|
|
2019
Q3 | $5.22M | Buy |
18,822
+4,616
| +32% | +$1.28M | 0.36% | 67 |
|
|
2019
Q2 | $4.45M | Buy |
14,206
+10,319
| +265% | +$3.23M | 0.17% | 111 |
|
|
2019
Q1 | $1.6M | Buy |
3,887
+52
| +1% | +$21.4K | 0.06% | 217 |
|
|
2018
Q4 | $1.43M | Sell |
3,835
-640
| -14% | -$239K | 0.12% | 134 |
|
|
2018
Q3 | $1.81M | Buy |
4,475
+10
| +0.2% | +$4.04K | 0.07% | 218 |
|
|
2018
Q2 | $1.54M | Buy |
4,465
+405
| +10% | +$140K | 0.06% | 271 |
|
|
2018
Q1 | $1.4M | Buy |
4,060
+124
| +3% | +$42.7K | 0.04% | 398 |
|
|
2017
Q4 | $1.48M | Buy |
3,936
+68
| +2% | +$25.6K | 0.04% | 426 |
|
|
2017
Q3 | $1.73M | Sell |
3,868
-432
| -10% | -$193K | 0.05% | 359 |
|
|
2017
Q2 | $2.11M | Buy |
4,300
+305
| +8% | +$150K | 0.06% | 283 |
|
|
2017
Q1 | $1.55M | Buy |
3,995
+758
| +23% | +$294K | 0.05% | 375 |
|
|
2016
Q4 | $1.19M | Buy |
3,237
+1,528
| +89% | +$561K | 0.03% | 471 |
|
|
2016
Q3 | $687K | Sell |
1,709
-2,294
| -57% | -$922K | 0.03% | 508 |
|
|
2016
Q2 | $1.4M | Buy |
4,003
+2,088
| +109% | +$729K | 0.06% | 275 |
|
|
2016
Q1 | $690K | Buy |
1,915
+870
| +83% | +$313K | 0.03% | 487 |
|
|
2015
Q4 | $567K | Buy |
1,045
+273
| +35% | +$148K | 0.03% | 521 |
|
|
2015
Q3 | $359K | Buy |
772
+285
| +59% | +$133K | 0.03% | 559 |
|
|
2015
Q2 | $248K | Buy |
+487
| New | +$248K | 0.01% | 819 |
|
|
2014
Q2 | – | Sell |
-1,339
| Closed | -$402K | – | 995 |
|
|
2014
Q1 | $402K | Buy |
1,339
+182
| +16% | +$54.6K | 0.03% | 506 |
|
|
2013
Q4 | $318K | Sell |
1,157
-182
| -14% | -$50K | 0.03% | 505 |
|
|
2013
Q3 | $419K | Buy |
1,339
+65
| +5% | +$20.3K | 0.05% | 331 |
|
|
2013
Q2 | $286K | Buy |
+1,274
| New | +$286K | 0.04% | 392 |
|